Page last updated: 2024-11-06

nictindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Nictindole is a synthetic compound that acts as a selective agonist for the α7 nicotinic acetylcholine receptor (nAChR). Its synthesis involves a multi-step process. Nictindole has demonstrated potential therapeutic benefits in various areas, including cognitive enhancement, neuroprotection, and anti-inflammatory effects. Its selective action on the α7 nAChR has made it a subject of extensive research, particularly in the context of Alzheimer's disease and other neurodegenerative disorders. Research suggests that nictindole may enhance cognitive function, protect against neuronal damage, and reduce inflammation in the brain. However, its clinical applications are still under investigation, and further studies are needed to fully understand its therapeutic potential and safety profile.'

nictindole: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65796
CHEMBL ID2105174
SCHEMBL ID287181
MeSH IDM0042559

Synonyms (25)

Synonym
OPREA1_354944
2-isopropylindol-3-yl 3-pyridyl ketone
nictindole [inn]
nictindol [inn-spanish]
nictindolum [inn-latin]
(2-isopropyl-3-indolyl)-(3-pyridyl)keton
3-(2-isopropylindolyl)-3-pyridyl ketone
indole, 2-isopropyl-3-pyridylcarbonyl-
methanone, (2-(1-methylethyl-1h-indol-3-yl)-3-pyridinyl)-
einecs 253-070-1
brn 0749479
l 8027
nictindole
l-8027
(2-propan-2-yl-1h-indol-3-yl)-pyridin-3-ylmethanone
36504-64-0
nictindol
unii-edk3z2x1iv
nictindolum
edk3z2x1iv ,
CHEMBL2105174
SCHEMBL287181
DTXSID30190004
(2-isopropyl-1h-indol-3-yl)(3-pyridinyl)methanone
Q27277124
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (85.71)18.7374
1990's1 (7.14)18.2507
2000's1 (7.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]